Brief: EMA Gratns Orphan Drug Designation To Toleranzia Drug Candidate TOL2
29/07/2019 13:42
July 29 (Reuters) - Toleranzia AB TOLE.TE :
* EMA GRATNS ORPHAN DRUG DESIGNATION TO CO'S DRUG CANDIDATE
TOL2
Source text for Eikon: ID:nWkr7Y6wPY
Further company coverage: TOLE.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Toleranzia AB
See all newsBrief: Swedish Companies Registration Office Permits Implementation of Flerie, Toleranzia's M&A
Brief: Toleranzia Q2 Net Income SEK -2.911 Million
Brief: Nasdaq Stockholm Approves Toleranzia’S Application For Delisting
Brief: Toleranzia Applies For Delisting Of Shares On Nasdaq
Brief: Toleranzia Approves Merger Plan Adopted By Boards Of Toleranzia, Flerie